180 Life Sciences Corp. [NASDAQ: ATNF] gained 12.01% or 0.85 points to close at $7.93 with a heavy trading volume of 1834475 shares. The company report on March 26, 2021 that 180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics.
NetworkNewsAudio – 180 Life Sciences Corp. (NASDAQ: ATNF) announces the availability of a broadcast titled, “Controlling Inflammation to Stop Disease.”.
To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast.
It opened the trading session at $7.06, the shares rose to $8.30 and dropped to $6.92, the range by which the price of stock traded the whole day. The daily chart for ATNF points out that the company has recorded -28.56% loss over the past six months. However, it is still -317.37% lower than its most recent low trading price.
If we look at the average trading volume of 2.22M shares, ATNF reached to a volume of 1834475 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about 180 Life Sciences Corp. [ATNF]:
The Average True Range (ATR) for 180 Life Sciences Corp. is set at 0.94 The Price to Book ratio for the last quarter was 8.71, with the Price to Cash per share for the same quarter was set at 0.02.
Trading performance analysis for ATNF stock
180 Life Sciences Corp. [ATNF] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 29.15. With this latest performance, ATNF shares gained by 86.59% in over the last four-week period, additionally sinking by -28.56% over the last 6 months – not to mention a drop of -23.90% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ATNF stock in for the last two-week period is set at 68.44, with the RSI for the last a single of trading hit 73.07, and the three-weeks RSI is set at 65.51 for 180 Life Sciences Corp. [ATNF]. The present Moving Average for the last 50 days of trading for this stock 5.41, while it was recorded at 7.05 for the last single week of trading, and 7.27 for the last 200 days.
180 Life Sciences Corp. [ATNF]: A deeper dive into fundamental analysis
When it comes to the capital structure of this company, 180 Life Sciences Corp. [ATNF] has a Total Debt to Total Equity ratio set at 53.51. Additionally, ATNF Total Debt to Total Capital is recorded at 34.86, with Total Debt to Total Assets ending up at 22.89.
180 Life Sciences Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.10 and a Current Ratio set at 0.10.
An analysis of insider ownership at 180 Life Sciences Corp. [ATNF]
There are presently around $13 million, or 6.50% of ATNF stock, in the hands of institutional investors. The top three institutional holders of ATNF stocks are: VANGUARD GROUP INC with ownership of 1,179,639, which is approximately New of the company’s market cap and around 17.20% of the total institutional ownership; BOOTHBAY FUND MANAGEMENT, LLC, holding 200,000 shares of the stock with an approximate value of $1.59 million in ATNF stocks shares; and MILLENNIUM MANAGEMENT LLC, currently with $0.67 million in ATNF stock with ownership of nearly New of the company’s market capitalization.
10 institutional holders increased their position in 180 Life Sciences Corp. [NASDAQ:ATNF] by around 1,537,973 shares. Additionally, 14 investors decreased positions by around 1,109,649 shares, while 1 investors held positions by with 1,021,365 shares. The mentioned changes placed institutional holdings at 1,626,257 shares, according to the latest SEC report filing. ATNF stock had 7 new institutional investments in for a total of 1,353,903 shares, while 13 institutional investors sold positions of 845,100 shares during the same period.